Obstructive and restrictive pulmonary diseases can be categorized based on pulmonary function tests. Obstructive diseases like emphysema and chronic bronchitis involve airflow limitation due to airway obstruction. Restrictive diseases like pulmonary fibrosis involve reduced lung expansion and capacity. Chronic obstructive pulmonary disease (COPD) encompasses chronic bronchitis and emphysema, both of which involve irreversible airway obstruction. Emphysema is defined as abnormal enlargement of airspaces distal to terminal bronchioles due to alveolar wall destruction. The main types are centriacinar and panacinar emphysema. Emphysema results from an imbalance between proteases and antiproteases degrading lung tissue in heavy smokers.
At the end of this lecture student able to:
Define COPD
List causes of COPD
List risk factors of COPD
List signs and symptoms of COPD
List diagnostic measures
Describe treatment of COPD
Identify complications of COPD
Use nursing process
Discuss relevant patient / family education
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
At the end of this lecture student able to:
Define COPD
List causes of COPD
List risk factors of COPD
List signs and symptoms of COPD
List diagnostic measures
Describe treatment of COPD
Identify complications of COPD
Use nursing process
Discuss relevant patient / family education
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
\It is a condition of the lung characterized by permanent dilatation of the air spaces distal to the terminal bronchioles with destruction of the walls of these airways.
Chronic Bronchitis
It is a disease characterized by daily cough with sputum for at least 3 months of the year for at least 2 consecutive years and airway obstruction which is irreversible.
What is COPD, what causes COPD? What is the pathophysiology?How can we diagnose COPD. What is it's classification depending on severity. How can we diagnose COPD clinically as well as under microscope.How can we treat and manage COPD with the help of medicine as well as socially. Let's discuss.
The latest guidelines on the management of a COPD patient ( Stable COPD, patient with an exacerbation of COPD), latest modalities of treatment of a COPD patient
Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), and chronic obstructive airway disease (COAD), among others, is a type of obstructive lung disease characterized by chronically poor airflow. It typically worsens over time. The main symptoms include shortness of breath, cough, and sputum production. Most people with chronic bronchitis have COPD.
Respiratory Tract Infections- A Pharmacotherapeutic ApproachDr. Ankit Gaur
In this presentation I have tried to explain the types, etiology, pathophysiology of respiratory tract infections such as bronchitis, pnemonia, otitis media, sinusitis, pharyngitis, and their treatment
\It is a condition of the lung characterized by permanent dilatation of the air spaces distal to the terminal bronchioles with destruction of the walls of these airways.
Chronic Bronchitis
It is a disease characterized by daily cough with sputum for at least 3 months of the year for at least 2 consecutive years and airway obstruction which is irreversible.
What is COPD, what causes COPD? What is the pathophysiology?How can we diagnose COPD. What is it's classification depending on severity. How can we diagnose COPD clinically as well as under microscope.How can we treat and manage COPD with the help of medicine as well as socially. Let's discuss.
The latest guidelines on the management of a COPD patient ( Stable COPD, patient with an exacerbation of COPD), latest modalities of treatment of a COPD patient
Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), and chronic obstructive airway disease (COAD), among others, is a type of obstructive lung disease characterized by chronically poor airflow. It typically worsens over time. The main symptoms include shortness of breath, cough, and sputum production. Most people with chronic bronchitis have COPD.
Respiratory Tract Infections- A Pharmacotherapeutic ApproachDr. Ankit Gaur
In this presentation I have tried to explain the types, etiology, pathophysiology of respiratory tract infections such as bronchitis, pnemonia, otitis media, sinusitis, pharyngitis, and their treatment
Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.
Pneumonia can range in seriousness from mild to life-threatening. It is most serious for infants and young children, people older than age 65, and people with health problems or weakened immune systems.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Diffuse pulmonary DiseaseDiffuse pulmonary Disease
• On the basis of deranged pulmonary physiology, i.e. based onOn the basis of deranged pulmonary physiology, i.e. based on
pulmonary function tests,pulmonary function tests,
Two categories:Two categories:
•(1)(1) obstructive diseaseobstructive disease (or(or airway diseaseairway disease), characterized by an), characterized by an
increase in resistance to airflow owing to partial or complete obstructionincrease in resistance to airflow owing to partial or complete obstruction
at any level, from the trachea and larger bronchi to the terminal andat any level, from the trachea and larger bronchi to the terminal and
respiratory bronchiolesrespiratory bronchioles
3. •(2)(2) restrictive disease,restrictive disease, ..
Characterized by reduced expansion of lung parenchyma, withCharacterized by reduced expansion of lung parenchyma, with
decreased total lung capacitydecreased total lung capacity
Although many conditions have both obstructive and restrictiveAlthough many conditions have both obstructive and restrictive
components.components.
4. Obstructive restrictive
characterized by limitation of airflow due
to partial or complete obstruction
characterized by reduced expansion of
lung parenchyma accompanied by
decreased total lung capacity.
Eg are emphysema, chronic bronchitis,
bronchiectasis, and asthma
Eg idiopathic pulmonary fibrosis,
interstitial pneumonia,
Pneumoconiosis,Sarcoidosis; and chest
wall neuromuscular diseases
total lung capacity normal decreased
decreased expiratory flow rate Normal or reduced
5.
6. Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)
It is a chronic progressive disorder of airway obstruction with a little orIt is a chronic progressive disorder of airway obstruction with a little or
no reversibility.no reversibility.
COPD includes –COPD includes –
Chronic BronchitisChronic Bronchitis
EmphysemaEmphysema
7. CHRONIC BRONCHITISCHRONIC BRONCHITIS
Bronchitis is an inflammation of the bronchi causing excessive mucousBronchitis is an inflammation of the bronchi causing excessive mucous
production and swelling of the bronchial walls.production and swelling of the bronchial walls.
Defn : -Defn : - It is defined clinically as persistence of cough withIt is defined clinically as persistence of cough with
expectoration{sputum} at least for 3 months in at least 2 consecutiveexpectoration{sputum} at least for 3 months in at least 2 consecutive
years. (Provided other causes of cough has been ecluded)years. (Provided other causes of cough has been ecluded)
8. ETIOPATHOGENESISETIOPATHOGENESIS : -: -
•It is more common in males of 30 to 40 yrs.It is more common in males of 30 to 40 yrs.
Two main etiological factorsTwo main etiological factors
1. Primary or initiating factor1. Primary or initiating factor
•Chronic inhalation of tobacco smoke and atmospheric pollutionChronic inhalation of tobacco smoke and atmospheric pollution
2. Contributory factor - Infections : - Like bacterias, viral & fungal2. Contributory factor - Infections : - Like bacterias, viral & fungal
10. PATHOLOGYPATHOLOGY : -: -
GROSS :GROSS :
Bronchial walls are thickened, oedematous, hyperaemic causingBronchial walls are thickened, oedematous, hyperaemic causing
bronchial lumens to be narrowed & filled with secretions.bronchial lumens to be narrowed & filled with secretions.
11. Microscopic :Microscopic :
Hypertrophy{inc. size of cell} of bronchial mucous glands &Hypertrophy{inc. size of cell} of bronchial mucous glands &
Increased in goblet cellsIncreased in goblet cells
Hypersecretion of mucusHypersecretion of mucus
Inflammation – hyperaemia{excess of blood in the vessels} &Inflammation – hyperaemia{excess of blood in the vessels} &
oedema of mucous membraneoedema of mucous membrane
FibrosisFibrosis
Bronchial squamous metaplasia and dysplasia{enlargement ofBronchial squamous metaplasia and dysplasia{enlargement of
organ by proliferation of cell} (smokers).organ by proliferation of cell} (smokers).
12.
13. Clinical findingsClinical findings
i. Cough, sputum production, dyspnea, frequent infectionsi. Cough, sputum production, dyspnea, frequent infections
ii. Hypoxia, cyanosis{blue discolouration of skin}ii. Hypoxia, cyanosis{blue discolouration of skin}
ComplicationsComplications
i. Increased risk for recurrent infectionsi. Increased risk for recurrent infections
ii. Pulmonary HTN leading to right heart failure (cor pulmonale)ii. Pulmonary HTN leading to right heart failure (cor pulmonale)
iii. Lung canceriii. Lung cancer
14. EmphysemaEmphysema
Definition:Definition:
It is defined as abnormal permanent enlargement of air spaces distalIt is defined as abnormal permanent enlargement of air spaces distal
to the terminal bronchioles with destruction of alvelolar walls.to the terminal bronchioles with destruction of alvelolar walls.
15. Types of EmphysemaTypes of Emphysema
There are 4 major types of emphysemaThere are 4 major types of emphysema
a.a. Centriacinar ( centrilobular)Centriacinar ( centrilobular)
b.b. Panacinar (Panlobular)Panacinar (Panlobular)
c.c. Paraseptal (Distal acinar)Paraseptal (Distal acinar)
d.d. Irregular emphysemaIrregular emphysema
This classification gives clue to etiology of the emphysema.This classification gives clue to etiology of the emphysema.
Only the first two cause clinically significant airflow obstructionOnly the first two cause clinically significant airflow obstruction
Centriacinar emphysema is far more common than the panacinarCentriacinar emphysema is far more common than the panacinar
form, constituting more than 95% of cases.form, constituting more than 95% of cases.
16. 1.1. Centriaciner emphysema –Centriaciner emphysema –
Central or proximal parts of the acini{cluster of cell}, formed byCentral or proximal parts of the acini{cluster of cell}, formed by
respiratory bronchioles, are affected, whereas distal alveoli arerespiratory bronchioles, are affected, whereas distal alveoli are
spared .spared .
Thus, both emphysematous and normal airspaces exist within theThus, both emphysematous and normal airspaces exist within the
same acinus and lobule.same acinus and lobule.
The lesions are more common and usually more severe in theThe lesions are more common and usually more severe in the
upper lobes.upper lobes.
Centriacinar type of emphysemaCentriacinar type of emphysema
usually occurs in heavy smokers.usually occurs in heavy smokers.
This is the commonest typeThis is the commonest type
17. 2. Panacinar emphysema –2. Panacinar emphysema –
Whole acinus is involvedWhole acinus is involved
Here, the acini are uniformly enlarged from the level of respiratoryHere, the acini are uniformly enlarged from the level of respiratory
bronchioles to the terminal blind alveoli.bronchioles to the terminal blind alveoli.
This type of emphysema are more common in the lower zones andThis type of emphysema are more common in the lower zones and
is associated with alpha -1 AT{antitrypsin} deficiency.{it decreasedis associated with alpha -1 AT{antitrypsin} deficiency.{it decreased
activiyi of blood or lungs}activiyi of blood or lungs}
20. 3. Paraseptal(Distal acinar emphysema)3. Paraseptal(Distal acinar emphysema)
Here, only the distal part of acinar are involved .Here, only the distal part of acinar are involved .
This type of emphysema lies very close to pleura and frequently leadsThis type of emphysema lies very close to pleura and frequently leads
to spontaneous pneumothorax(presence of air or gas in the cavity into spontaneous pneumothorax(presence of air or gas in the cavity in
lungs).lungs).
It occurs adjacent to the area of fibrosis or atelectasis(collapse of lungs)It occurs adjacent to the area of fibrosis or atelectasis(collapse of lungs)
It is more common in the upper half of the lungs.It is more common in the upper half of the lungs.
21. Irregular emphysema –Irregular emphysema –
Here the acinus is irregularly involved and always associated withHere the acinus is irregularly involved and always associated with
scarring.scarring.
It is asymptomatic.It is asymptomatic.
Conditions related to emphysema:Conditions related to emphysema:
Compensatory emphysemaCompensatory emphysema
compensatory dilatation of alveoli in response to loss of lungcompensatory dilatation of alveoli in response to loss of lung
substance elsewhere (e.g. after lobectomy)substance elsewhere (e.g. after lobectomy)
interstitial – mediastinal emphysemainterstitial – mediastinal emphysema
entrance of air into the connective tissue of the lungs mediastinum orentrance of air into the connective tissue of the lungs mediastinum or
subcutaneous tissuesubcutaneous tissue
22. Obstructive OverinflationObstructive Overinflation
Condition in which the lungs expands because air is trapped within itCondition in which the lungs expands because air is trapped within it
. Eg. Tumour, foreign body. Eg. Tumour, foreign body
Bullous emphysemaBullous emphysema
Any form of emphysema that produces large subpleural blebs orAny form of emphysema that produces large subpleural blebs or
bullae (>1 cm).bullae (>1 cm).
Generally gives rise to pneumothoraxGenerally gives rise to pneumothorax
23. AetiopathogenesisAetiopathogenesis
Smoke- chronic bronchitis- in filtration of lung tissue by inflammatorySmoke- chronic bronchitis- in filtration of lung tissue by inflammatory
cells - liberate Enzymes elastase, proteinase, etc- destruction ofcells - liberate Enzymes elastase, proteinase, etc- destruction of
elastic tissue- dilation of respiratory unit - Emphysemaelastic tissue- dilation of respiratory unit - Emphysema
Hereditary deficiency of a1 antitrypsin- unopposed action of enzymeHereditary deficiency of a1 antitrypsin- unopposed action of enzyme
elastase- destruction of elastic tissue of lungs- dilation of respiratoryelastase- destruction of elastic tissue of lungs- dilation of respiratory
unit- Emphysemaunit- Emphysema
Therefore, emphysema is the product of an imbalance between theTherefore, emphysema is the product of an imbalance between the
proteinases and antiproteinases in favor of proteinases.proteinases and antiproteinases in favor of proteinases.
28. Histologically:
1.Abnormal enlargement of airspaces.
2.Thinning and destruction of septal walls.
3.Compression of the septal capillaries; fibrous thickness of intima of the
pulmonary small arteries.
•Bronchiolitis involving the terminal and respiratory bronchioles.
29. Pulmonary emphysema. There is marked enlargement of airspaces, with
thinning and destruction of alveolar septa
30. Clinical findings
i. Progressive dyspnea
ii. Pursing of lips and use of accessory muscles to breathe
iii. Barrel chest
iv. Weight loss
31.
32.
33. Define COPD. What are the diseases encompassingDefine COPD. What are the diseases encompassing
COPDCOPD
Define emphysema. What are the types of emphysemaDefine emphysema. What are the types of emphysema
Give the pathogenesis of emphysemaGive the pathogenesis of emphysema
Write down the differences between emphysema &Write down the differences between emphysema &
chronic Bronchitischronic Bronchitis